Syngene International informs about updates

15 Nov 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, Syngene International has informed that the US Food and Drug Administration (FDA) has conducted its pre-approval inspection of the Biologics facility at Bangalore from November 07, 2022 till November 15, 2022. The inspection was completed successfully without 483 observations. The above-mentioned information will also be available on website of the Company www.syngeneintl.com.

The above information is a part of company’s filings submitted to BSE.

Syngene Internation. Share Price

603.70 2.85 (0.47%)
22-Jan-2026 11:22 View Price Chart
Peers
Company Name CMP
Syngene Internation. 603.70
Indegene 480.40
CMS Info Systems 328.80
Sagility 52.45
Smartworks Coworking 440.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×